Intensity Therapeutics (INTS) Selling, General & Administrative (2022 - 2026)
Intensity Therapeutics (INTS) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | 1.13 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | 216.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 593.21 Mn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | 347.92 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -196.26 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 247.47 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 161.89 Mn |
| 10 | Intensity Therapeutics | 12.56 Mn | 12.56 Mn | - | 1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.25 Mn |
| Mar 31, 2026 | 1.33 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 362,000.00 |
| Mar 31, 2023 | 480,000.00 |
| Dec 31, 2022 | 583,034.00 |
| Sep 30, 2022 | 607,113.00 |
| Jun 30, 2022 | 543,830.00 |